Bovie Medical Corporation Announces the Filing of an FDA 510(k) Application for New Laparoscopic Instruments.

MELVILLE, N.Y. -- Bovie Medical Corporation (the "Company") (Amex: BVX), a manufacturer and marketer of electrosurgical products, today announced the filing of a 510(k) application for a new line of patent pending advanced modular laparoscopic electrosurgical electrodes and handle aimed at the laparoscopic and arthroscopic markets. The Modular Ergonomic Instruments (MEG) family is an innovative advancement of current hand instruments used in electrosurgery. The MEG line combined with Bovie's advanced electrosurgical generators offers users unprecedented cost savings as well as reduced and simplified inventory.

The high quality, reusable, insulated MEG line handle comes with light metallic grips, transparent ratchet and ergonomic design, which should reduce surgeon fatigue and improve tactile feel. The handle accepts reusable tip inserts. Additionally, the loading and detachment of tips is simple with minimal required user training.

Commercial prototypes have been developed and Bovie plans to commence marketing after necessary clearance from the FDA. It has been estimated that the total annual worldwide market for this product line exceeds $200 million.

The Company's annual meeting of common stockholders will be held September 14, 2006 at 5:00 p.m., eastern daylight savings time at the Holiday Inn, 215 Sunnyside Boulevard, Plainview, New York 11803.

This document may contain some forward looking statements, particularly regarding operational prospects in 2006 and beyond, which involve a number of risks and uncertainties that could cause actual results to differ materially. These risks are listed from time to time in the Company's SEC filings.